BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 35861981)

  • 1. Reverse Remodeling Following Valve Replacement in Coexisting Aortic Stenosis and Transthyretin Cardiac Amyloidosis.
    Nitsche C; Koschutnik M; Donà C; Radun R; Mascherbauer K; Kammerlander A; Heitzinger G; Dannenberg V; Spinka G; Halavina K; Winter MP; Calabretta R; Hacker M; Agis H; Rosenhek R; Bartko P; Hengstenberg C; Treibel T; Mascherbauer J; Goliasch G
    Circ Cardiovasc Imaging; 2022 Jul; 15(7):e014115. PubMed ID: 35861981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unveiling transthyretin cardiac amyloidosis and its predictors among elderly patients with severe aortic stenosis undergoing transcatheter aortic valve replacement.
    Castaño A; Narotsky DL; Hamid N; Khalique OK; Morgenstern R; DeLuca A; Rubin J; Chiuzan C; Nazif T; Vahl T; George I; Kodali S; Leon MB; Hahn R; Bokhari S; Maurer MS
    Eur Heart J; 2017 Oct; 38(38):2879-2887. PubMed ID: 29019612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amyloid Transthyretin Cardiomyopathy in Elderly Patients With Aortic Stenosis Undergoing Transcatheter Aortic Valve Implantation.
    Dobner S; Pilgrim T; Hagemeyer D; Heg D; Lanz J; Reusser N; Gräni C; Afshar-Oromieh A; Rominger A; Langhammer B; Reineke D; Windecker S; Stortecky S
    J Am Heart Assoc; 2023 Aug; 12(16):e030271. PubMed ID: 37581394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transthyretin cardiac amyloidosis in patients with severe aortic stenosis undergoing transcatheter aortic valve replacement: experience of a single center.
    Gallone G; Bongiovanni C; Bruno F; Landra F; Andreis A; Fava A; Scudeler L; DE Filippo O; Califaretti E; Cioffi M; Pidello S; Vairo A; Raineri C; Frea S; Giorgi M; Alunni G; Casoni R; Salizzoni S; Conrotto F; D'Ascenzo F; Rinaldi M; DE Ferrari GM
    Minerva Cardiol Angiol; 2024 Feb; 72(1):87-94. PubMed ID: 37405712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Routine 4D Cardiac CT to Identify Concomitant Transthyretin Amyloid Cardiomyopathy in Older Adults with Severe Aortic Stenosis.
    Bernhard B; Leib Z; Dobner S; Demirel C; Caobelli F; Rominger A; Schütze J; Grogg H; Alwan L; Spano G; Boscolo Berto M; Lanz J; Pilgrim T; Windecker S; Stortecky S; Gräni C
    Radiology; 2023 Dec; 309(3):e230425. PubMed ID: 38085082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of afterload and infiltration on coexisting aortic stenosis and transthyretin amyloidosis.
    Patel KP; Scully PR; Nitsche C; Kammerlander AA; Joy G; Thornton G; Hughes R; Williams S; Tillin T; Captur G; Chacko L; Kelion A; Sabharwal N; Newton JD; Kennon S; Ozkor M; Mullen M; Hawkins PN; Gillmore JD; Menezes L; Pugliese F; Hughes AD; Fontana M; Lloyd G; Treibel TA; Mascherbauer J; Moon JC
    Heart; 2022 Jan; 108(1):67-72. PubMed ID: 34497140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unveiling outcomes in coexisting severe aortic stenosis and transthyretin cardiac amyloidosis.
    Rosenblum H; Masri A; Narotsky DL; Goldsmith J; Hamid N; Hahn RT; Kodali S; Vahl T; Nazif T; Khalique OK; Bokhari S; Soman P; Cavalcante JL; Maurer MS; Castaño A
    Eur J Heart Fail; 2021 Feb; 23(2):250-258. PubMed ID: 32729170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In the midst of a dangerous intersection with unclear therapeutic strategies: a challenging case of severe aortic stenosis.
    Gallone G; Landra F; D'Ascenzo F; Conrotto F; Casoni R; Bruno F; Omedè P; Alunni G; Andreis A; Vairo A; Giorgi M; Fava A; De Ferrari GM
    BMC Cardiovasc Disord; 2020 Jun; 20(1):261. PubMed ID: 32487051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and Outcomes of Concomitant Aortic Stenosis and Cardiac Amyloidosis.
    Nitsche C; Scully PR; Patel KP; Kammerlander AA; Koschutnik M; Dona C; Wollenweber T; Ahmed N; Thornton GD; Kelion AD; Sabharwal N; Newton JD; Ozkor M; Kennon S; Mullen M; Lloyd G; Fontana M; Hawkins PN; Pugliese F; Menezes LJ; Moon JC; Mascherbauer J; Treibel TA
    J Am Coll Cardiol; 2021 Jan; 77(2):128-139. PubMed ID: 33181246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transthyretin cardiac amyloidosis in patients after TAVR: clinical and echocardiographic findings and long term survival.
    Shimoni S; Zikri M; Haberman D; Livschitz S; Tshori S; Fabricant Y; Meledin V; Gandelman G; Goland S; George J
    ESC Heart Fail; 2021 Dec; 8(6):4549-4561. PubMed ID: 34704399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Occult Transthyretin Cardiac Amyloid in Severe Calcific Aortic Stenosis: Prevalence and Prognosis in Patients Undergoing Surgical Aortic Valve Replacement.
    Treibel TA; Fontana M; Gilbertson JA; Castelletti S; White SK; Scully PR; Roberts N; Hutt DF; Rowczenio DM; Whelan CJ; Ashworth MA; Gillmore JD; Hawkins PN; Moon JC
    Circ Cardiovasc Imaging; 2016 Aug; 9(8):. PubMed ID: 27511979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of ATTR-CA and high-risk features to guide testing in patients referred for TAVR.
    Abadie B; Ali AH; Martyn T; Higgins A; Krishnaswamy A; Reed G; Puri R; Yun J; Cremer P; Hanna M; Tang WHW; Kapadia S; Jaber W
    Eur J Nucl Med Mol Imaging; 2023 Nov; 50(13):3910-3916. PubMed ID: 37606857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of new-onset arrhythmia on cardiac reverse remodeling following transcatheter aortic valve replacement: computed tomography-derived left ventricular and atrial strains.
    Park S; Kang DY; Ahn JM; Kim DH; Park DW; Park SJ; Kang JW; Yang DH; Lee SA; Koo HJ
    Eur Radiol; 2023 Dec; 33(12):8454-8463. PubMed ID: 37368107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversibility of Cardiac Function Predicts Outcome After Transcatheter Aortic Valve Replacement in Patients With Severe Aortic Stenosis.
    Sato K; Kumar A; Jones BM; Mick SL; Krishnaswamy A; Grimm RA; Desai MY; Griffin BP; Rodriguez LL; Kapadia SR; Obuchowski NA; Popović ZB
    J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28698259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and outcome of dual aortic stenosis and cardiac amyloid pathology in patients referred for transcatheter aortic valve implantation.
    Scully PR; Patel KP; Treibel TA; Thornton GD; Hughes RK; Chadalavada S; Katsoulis M; Hartman N; Fontana M; Pugliese F; Sabharwal N; Newton JD; Kelion A; Ozkor M; Kennon S; Mullen M; Lloyd G; Menezes LJ; Hawkins PN; Moon JC
    Eur Heart J; 2020 Aug; 41(29):2759-2767. PubMed ID: 32267922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concomitant Transthyretin Amyloidosis and Severe Aortic Stenosis in Elderly Indian Population: A Pilot Study.
    Singal AK; Bansal R; Singh A; Dorbala S; Sharma G; Gupta K; Saxena A; Bhargava B; Karthikeyan G; Ramakrishnan S; Bisoi AK; Hote MP; Rajashekar P; Chowdhury UK; Devagourou V; Patel C; Ray R; Arawa SK; Mishra S
    JACC CardioOncol; 2021 Oct; 3(4):565-576. PubMed ID: 34746852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Impact of bicuspid aortic valve or tricuspid aortic valve on hemodynamics and left ventricular reverse remodeling in patients after transcatheter aortic valve replacement].
    Zhang JQ; Chi CW; Zhao WL; Meng QT; Wang LD; Liu JY; Sun FZ; Zhang SL; Liu JH
    Zhonghua Xin Xue Guan Bing Za Zhi; 2022 Dec; 50(12):1193-1200. PubMed ID: 36517440
    [No Abstract]   [Full Text] [Related]  

  • 18. Quantification of Myocardial Extracellular Volume With Planning Computed Tomography for Transcatheter Aortic Valve Replacement to Identify Occult Cardiac Amyloidosis in Patients With Severe Aortic Stenosis.
    Oda S; Kidoh M; Takashio S; Inoue T; Nagayama Y; Nakaura T; Shiraishi S; Tabata N; Usuku H; Kaikita K; Tsujita K; Ikeda O
    Circ Cardiovasc Imaging; 2020 May; 13(5):e010358. PubMed ID: 32370615
    [No Abstract]   [Full Text] [Related]  

  • 19. B-type natriuretic peptide is associated with remodeling and exercise capacity after transcatheter aortic valve replacement for aortic stenosis.
    Sato K; Kumar A; Krishnaswamy A; Mick S; Desai MY; Griffin BP; Kapadia SR; Popović ZB
    Clin Cardiol; 2019 Feb; 42(2):270-276. PubMed ID: 30565264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic utility of the Perugini grading of 99mTc-DPD scintigraphy in transthyretin (ATTR) amyloidosis and its relationship with skeletal muscle and soft tissue amyloid.
    Hutt DF; Fontana M; Burniston M; Quigley AM; Petrie A; Ross JC; Page J; Martinez-Naharro A; Wechalekar AD; Lachmann HJ; Quarta CC; Rezk T; Mahmood S; Sachchithanantham S; Youngstein T; Whelan CJ; Lane T; Gilbertson JA; Rowczenio D; Hawkins PN; Gillmore JD
    Eur Heart J Cardiovasc Imaging; 2017 Dec; 18(12):1344-1350. PubMed ID: 28159995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.